University of Pennsylvania, Advaxis deal

The partners amended the financial terms of a 2002 deal that gave Advaxis exclusive, worldwide rights to the university’s patents covering Listeria vaccine technology. The partners eliminated a $400,000 milestone payment the university was eligible to receive at the start of

Read the full 419 word article

How to gain access

Continue reading with a
two-week free trial.